BSEBoard Meeting13h ago · 7 Aug 2026, 07:11 pm
Outcome of Board Meeting held on August 07, 2026
Evexia Lifecare Ltd · 524444
✦ AI SummaryResults
Evexia Lifecare Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with a net profit of Rs. 41.49 crores.
Analysis Scores
Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Evexia Lifecare Ltd - 524444 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 07, 2026
Attachments (1)
📄pdf
Download →
8c1ef45e-1e52-4d8c-9887-0d86236e1c85.pdf
View document text
eve’<ia
L) ®
EVEXIA LIFECARE LIMITED
(Formerly Known as Kavit Industries Ltd.)
August 07, 2026
BSE Ltd.
P. J. Towers
Dalal Street,
Mumbai - 400 001.
BSE Scrip Code: 524444
Subject: Outcome of the Board Meeting held on August 07,2026
Dear Sir,
Pursuant to Regulation 30 and Regulation 33 of SEBI (LODR) Regulations, 2015 we wish to
inform you that the Board of Directors at its meeting held today i.e. 7th August, 2026 have
inter-alia considered and approved the following matters.
1. The Un-audited Standalone & Consolidated Financial Results of the Company for the
Quarter ended June 30, 2026.
2. Limited Review Report on the said Results issued by the Statutory Auditors for the Quarter
ended June 30, 2026.
The Board Meeting started at 17.00 p.m. and ended at 19.00 p.m.
Kindly take the same on record.
Thanking You,
Yours faithfully,
FOR EVEXIA LIFECARE LI
MANAGING DIRECTOR
DIN: 01631093
Encl: As above
Reg. Off. : Tundav Anjesar Raod, Vill. Tundav, Tal.: Savli, Vadodara - 391 775
Corporate Office : 9th Floor, Galav Chambers, Sayajigunj, Vadodara-390 020. Ph : +91 265 2361100 / 2200
CIN : L23100GJ1990PLCO14692 Email : info@evexialifecare.com Web.: www.evexialifecare.com
EVEXIA LIFECARE LIMITED
CIN NO. : L23100GI1990PLC014692
Regd. Office: VI: TLUNDLAO, TAL: SALVI, Vadodara, VADODARA, Gujarat, India, 391775
E-mail id: info@evexialifecare.com Phone: (0265) 2362200/1100 website: www.evexialifecare.com
STATEMENT OF UN-AUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED ON JUNE 30, 2026
(Rs. In Lakhs Except EPS and Face Value of Share)
Quarter Ended
Year Ended
Particulars June 30, 2026 March 31, 2026 June 30, 2025 March 31, 2026
Un-Audited Audited Un-Audited Audited
I| Revenue from operations 2,965.91 3,517.94 2,065.80 10,546.47
II| Other Income 215 54.63 = 88.56
III| Total Revenue (I+II) 2,968.06 3,572.57 2,065.80 10,635.03
Iv| Expenses
Cost of material consumed = = = =
Purchase of stock in trade 2,884.29 3,411.50 1,981.41 10,142.35
Changes in inventories of Finished Goods, (7.82) 32.04 (47.46) 40.64
Work-in-Progress and Stock-in-trade
Employee benefits expenses 5.84 16.25 16.98 67.07
Finance Costs 0.12 0.34 0.69 0.60
Depreciation and amortization expense 11.19 30.53 11.91 66.26
Other Expenses 18.37 25.37 22.96 112.56
Total Expenses 2,911.99 3,516.02 1,986.49 10,429.48
V| Profit before exceptional and 56.07 56.54 79.31 205.55
extraordinary items and tax (III-IV)
VI Exceptional Items = = e &
VII| Profit before extraordinary items and tax 56.07 56.54 79.31 205.55
(V-VI)
VIII| Extraordinary items = = = 2
IX| Profit before tax (VII-VIII) 56.07 56.54 79.31 205.55
X| Tax Expenses 14.58 9.58 20.62 53.44
1) Current tax 14.58 9.58 20.62 53.44
2) Deferred tax = = = =
3) Short/ (Excess) Provision of Income Tax of = S % =
Previous Years
XI| Profit (Loss) for the period from 41.49 46.96 58.69 152.10
continuing operations (IX-X)
XII| Profit / (Loss) from discontinuing B - - 5
operations
XIII| Tax expenses of discontinuing operations = = = -
XIV[ Profit/ (Loss) from discontinuing operations - - B =
(after tax) (XII-XIII)
XV| Net Profit / (Loss) for the period 41.49 46.96 58.69 152.10
(XI+XIV)
XVI| Other Comprehensive income - - g -
'A) (i) Ttems that will not be reclassified to profit B - 2 -
or loss
(ii) Income tax relating to items that will not - - B -
be reclassified to profit or lo:
B) (i) Items that will be reclassified to profit or - - - -
(ii) Income tax relating to items that will be - = - -
reclassified to profit or lo
XVII| Total Comprehensive Income 41.49 46.96 58.69 152.10
XVIII| Paid up Equity Share Capital (Face Value 18,773.29 18,773.29 18,773.29 18,773.29
Rs. 1/- each)
XIX| Other Equity excluding Revaluation =) = - -
Reserve
XX|_Earnipnegr share
1) Basic 0.002 0.003 0.003 0.008
2) Diluted 0.002 0.003 0.003 0.008
FOR, EVEXIA LIFECARE LIMITED
RAICHANDBHAI THAKKAR
DATE: 07.08.2026 CHAIRMAN & MANAGING DIRECTOR
PLACE: VADODARA DIN : 01631093
Notes to Standalone Financial Resuits - Q1 FY 2026-2027
1 The above results which are published have been reviewed and approved by the Board of Directors of the
Company at their meeting held on 07th August 2026. The financial results of the Company have been
prepared in accordance with the Indian Accounting Standards (Ind AS) as prescribed under Section 133 of
the Companies Act, 2013 read with relevant rules Issued thereunder and the other accounting principles
generally accepted In India.) The unaudited financial results for the quarter ended June 30th 2026 have
been subjected to limited review by the Statutory Auditors.
2 The above standalone financial results have been reviewed and recommended by Audit Committee and
have been approved and taken on record by Board of Directors at its meeting on 07th August 2026.
3 The limited review as required under Regulation 33 of the SEBI (Listing Obligation and Disclosure
Requirements) Regulations, 2015 has been completed by the auditors of Company.
4 Figures for the previous periods have been regrouped and/or rearranged and/or reclassified wherever
necessary to make them comparable with those of current periods.
5 During the quarter ended 30 June 2026, the Company, pursuant to the Board Resolution No. 6 dated
09.05.2026, approved the forfeiture of 24,00,00,000 Convertible Warrants issued on a preferential basis at
23.60 per warrant. As per the terms of issue and Regulation 169 of the SEBI (Issue of Capital and
Disclosure Requirements) Regulations, 2018, the warrant holders had paid 25% of the warrant issue price
upfront. Since the balance 75% of the consideration was not received and the warrants were not exercised
within the stipulated period of 18 months from the date of allotment, the warrants stood forfeited.
Consequently, the amount received on such warrants aggregating to 221.60 Crore has been transferred to
Capital Reserve. The said transaction has no impact on the Company's profitability for the quarter ended
30th June 2026.
6 Pursuant to the alteration of the Object Clause of the Memorandum of Association approved by the
shareholders in the previous period, the Company commenced operations under its new division, Go
EVEXIA, engaged in Electric Vehicle (EV) rental and mobility solutions during the quarter ended 30th June
2026. The commencement of this business marks the Company's entry into a new line of business, distinct
from its existing operations, with the objective of expanding and diversifying its revenue streams.
Revenue from operations under the Go EVEXIA division for the quarter ended 30 June 2026 amounted to
%2.72 Lakhs. As the business is in its initial phase of operations, its contribution to the Company's overall
revenue remains limited. The management believes that the EV mobility sector offers significant long-term
growth potential.
7 Basic EPS and Diluted EPS has been Calculated with Total No. of Equity Shares held as on 30.06.2026 i.
187,73,28,995.
CARN FOR, EVEXIA
DATE: 07.08.2026 . \DO! N | JANDBHAI THAKKAR
PLACE: VADODARA ; - CHAIRMAN & MANAGING DIRECTOR
2N\ ) DIN : 01631093
Tejas K. Soni & Company W +919408151293 ¥ info@tksoni.co.in
© +919723451293 www.tksoni.co.in
Limited Review Report on Un-Audited Standalone Quarterly Financial Results of
EVEXIA LIFECARE LIMITED pursuant to the Regulation 33 of the SEBI (Listing
Obligation and Disclosure Requirement) Regulations, 2015 for the period
ended on June 30, 2026.
Board of Directors of
EVEXIA LIFECARE LIMITED
INTRODUCTION
1. We have reviewed the accompanying statement of Un-Audited Standalone Financial
Results of EVEXIA LIFECARE LIMITED (“the Company”) for the quarter ended on
June 30, 2026 (“the Statement”) attached herewith. This Statement, which is the
responsibility of the Company’s Management and approved by the Company’s Board
of Directors, has been prepared pursuant to the requirements Regulation 33 of the
SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 as
amended.
2. This Statement, which is the responsibility of the Company’s Management and
approved by the Company’s Bo
[Showing first 8,000 characters — download PDF for full document]